Znn3bq.jpeg
²é¿´: 331  |  »Ø¸´: 2
±¾Ìû²úÉú 1 ¸ö £¬µã»÷ÕâÀï½øÐв鿴

Æø³Áµ¤Ìï

ľ³æ (СÓÐÃûÆø)

[ÇóÖú] Çë°ïæ ²éÒ»ÏÂÎÄÏ×SCIÊÕ¼Çé¿ö

Biomed Pharmacother. 2016 Dec;84:1274-1281. doi: 10.1016/j.biopha.2016.10.040. Epub 2016 Oct 28.
The microRNA-635 suppresses tumorigenesis in non-small cell lung cancer.
Zhang Y, Sun Z, Zhang Y, Fu T, Liu C, Liu Y, Lin Y
Íò·Ö¸Ðл

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

polymer1211

ľ³æÖ®Íõ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Æø³Áµ¤Ìï: ½ð±Ò+20, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2017-10-11 11:11:40
Ðľ²_ÒÀÈ»: LS-EPI+1, ¸ÐлӦÖú 2017-10-11 12:19:41
Web of Science
µÚ 1 Ò³ (¼Ç¼ 1 -- 1)
ÉÏÒ»Ò³ (²»»î¶¯) [ 1 ] ÏÂÒ»Ò³ (²»»î¶¯)
´òÓ¡´ËÒ³
µÚ 1 Ìõ£¬¹² 1 Ìõ
±êÌâ: The microRNA-635 suppresses tumorigenesis in non-small cell lung cancer
×÷Õß: Zhang, Y (Zhang, Yan); Sun, ZW (Sun, Zongwen); Zhang, YQ (Zhang, Yanqun); Fu, T (Fu, Tian); Liu, C (Liu, Cun); Liu, YR (Liu, Yongrui); Lin, Y (Lin, Yong)
À´Ô´³ö°æÎï: BIOMEDICINE & PHARMACOTHERAPY  ¾í: 84  Ò³: 1274-1281  DOI: 10.1016/j.biopha.2016.10.040  ³ö°æÄê: DEC 2016  
Web of Science ºËÐĺϼ¯ÖÐµÄ "±»ÒýƵ´Î": 2
±»ÒýƵ´ÎºÏ¼Æ: 2
ʹÓôÎÊý (×î½ü 180 Ìì): 1
ʹÓôÎÊý (2013 ÄêÖÁ½ñ): 3
ÒýÓõIJο¼ÎÄÏ×Êý: 35
ÕªÒª: The microRNAs represent a class of noncoding RNAs with short length and play diverse roles in many biological processes. Despite tremendous effects have been devoted, the role of miR-635 in non-small cell lung cancer (NSCLC) remains elusive. Here we report a potential tumor suppressive function of miR-635 in NSCLC. By microRNA screening based on invasion assays, we identified series of functional miRNAs. The miR-635 was then identified as a potent inhibitor of cell invasion and differentially expressed in normal and cancerous tissues. We further confirmed that Ying Yang 1 (YY1) may be the direct target of miR-635 as miR-635 transfection can significantly decrease endogenous YY1 expression which can mimic the effect of siRNA-mediated YY1 knockdown. Meanwhile, both miR-635 transfection and YY1 silencing can attenuate NSCLC cell invasion. In addition, miR-635 transfection can also significantly inhibit the growth of xenograft tumors. Taken together, our results have suggested a novel tumor suppressive role for miR-635 in NSCLC. (C) 2016 Elsevier Masson SAS. All rights reserved.
Èë²ØºÅ: WOS:000390438100149
PubMed ID: 27810784
ÓïÖÖ: English
ÎÄÏ×ÀàÐÍ: Article
×÷Õ߹ؼü´Ê: miR-635; Invasion; YY1; NSCLC
KeyWords Plus: NSCLC; METASTASIS; EXPRESSION; BIOMARKERS; INVASION; IDENTIFICATION; PROLIFERATION; PROGRESSION; STATISTICS; TUMORS
µØÖ·: [Zhang, Yan; Fu, Tian; Liu, Yongrui; Lin, Yong] Jining 1 Peoples Hosp, Dept Resp Med, 6 Hlth Rd, Jining 272011, Shandong, Peoples R China.
[Sun, Zongwen] Jining 1 Peoples Hosp, Dept Oncol, Jining 272011, Peoples R China.
[Zhang, Yanqun] Laiwu Peoples Hosp, Dept Hlth Care, Laiwu 271100, Peoples R China.
[Liu, Cun] Jining 1 Peoples Hosp, Dept Clin Lab, Jining 272011, Peoples R China.
ͨѶ×÷ÕßµØÖ·: Lin, Y (ͨѶ×÷Õß),Jining 1 Peoples Hosp, Dept Resp Med, 6 Hlth Rd, Jining 272011, Shandong, Peoples R China.
µç×ÓÓʼþµØÖ·: linyong_jph@163.com
³ö°æÉÌ: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
³ö°æÉ̵ØÖ·: 23 RUE LINOIS, 75724 PARIS, FRANCE
Web of Science Àà±ð: Medicine, Research & Experimental; Pharmacology & Pharmacy
Ñо¿·½Ïò: Research & Experimental Medicine; Pharmacology & Pharmacy
IDS ºÅ: EF6JU
ISSN: 0753-3322
eISSN: 1950-6007
29 ×Ö·ûµÄÀ´Ô´³ö°æÎïÃû³ÆËõд: BIOMED PHARMACOTHER
ISO À´Ô´³ö°æÎïËõд: Biomed. Pharmacother.
À´Ô´³ö°æÎïÒ³Âë¼ÆÊý: 8
¹«¿ª·ÃÎÊ: No
Êä³öÈÕÆÚ: 2017-10-10

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

2Â¥2017-10-11 11:04:38
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Æø³Áµ¤Ìï

ľ³æ (СÓÐÃûÆø)

Ëͺ컨һ¶ä
ÒýÓûØÌû:
2Â¥: Originally posted by polymer1211 at 2017-10-11 11:04:38
Web of Science
µÚ 1 Ò³ (¼Ç¼ 1 -- 1)
ÉÏÒ»Ò³ (²»»î¶¯)  ÏÂÒ»Ò³ (²»»î¶¯)
´òÓ¡´ËÒ³
µÚ 1 Ìõ£¬¹² 1 Ìõ
±êÌâ: The microRNA-635 suppresses tumorigenesis in non-small cell lung cancer
×÷Õß: Zhang, Y (Zha ...

·Ç³£¸Ðл
3Â¥2017-10-11 11:10:02
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Æø³Áµ¤Ìï µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏÀà284µ÷¼Á +40 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-08 48/2400 2026-04-10 23:28 by 314126402
[¿¼ÑÐ] 281Çóµ÷¼Á +9 ¾õµÃºÃµÄ°É 2026-04-10 9/450 2026-04-10 22:16 by Öí»á·É
[¿¼ÑÐ] Çóµ÷¼Á +16 MAXâê㯠2026-04-09 18/900 2026-04-10 20:24 by С¹íม«¡«
[¿¼ÑÐ] 343Çóµ÷¼Á +5 Íõ¹ú˧ 2026-04-10 5/250 2026-04-10 16:56 by Öí»á·É
[¿¼ÑÐ] 296Çóµ÷¼Á +6 Íô£¡£¿£¡ 2026-04-08 6/300 2026-04-10 11:02 by mattzhming
[¿¼ÑÐ] Ò»Ö¾Ô¸211 0703»¯Ñ§ 346·ÖÇóµ÷¼Á +22 ÍÁ¶¹er? 2026-04-09 23/1150 2026-04-10 10:58 by ¸ßά´º
[¿¼ÑÐ] Çóµ÷¼Á +5 archer.. 2026-04-09 7/350 2026-04-09 22:18 by lbsjt
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí³µÁ¾ 281 Çóµ÷¼Á +5 Éϰ¶Ñо¿Éú. 2026-04-07 5/250 2026-04-09 15:56 by onlyÖÜ
[¿¼ÑÐ] µ÷¼Á +12 ÔÂ@163.com 2026-04-08 12/600 2026-04-09 14:27 by rl1980
[¿¼ÑÐ] 265Çóµ÷¼Á +4 ·ç˵ËýÔçÍüÁË 2026-04-07 4/200 2026-04-09 13:59 by onlyÖÜ
[¿¼ÑÐ] Çóµ÷¼Á£¬262»úеר˶ +6 àÅyyl 2026-04-08 6/300 2026-04-09 12:01 by zhouyuwinner
[¿¼ÑÐ] ¶þ´Îµ÷¼ÁÇóÀÏʦÊÕÁô +3 ЦЦԬ 2026-04-08 3/150 2026-04-08 23:50 by ×íÔÚ·çÀï
[¿¼ÑÐ] ÉúÎïѧ328·ÖÇóµ÷¼Á +9 ÉÁµçkkl 2026-04-08 10/500 2026-04-08 21:42 by liuhuiying09
[¿¼ÑÐ] 259Çóµ÷¼Á +5 ¾Í°®³ÔÍÁ¶¹Ñ½Ñ½ 2026-04-07 5/250 2026-04-07 22:40 by JourneyLucky
[¿¼ÑÐ] 22408 318·ÖÇóµ÷¼Á +4 ÇڷܵÄСÁý°ü 2026-04-06 6/300 2026-04-07 15:05 by Ö½º×555
[¿¼ÑÐ] »úеר˶274Çóµ÷¼Á£¬²»ÌôרҵѧУ +6 ·º·º2333 2026-04-05 8/400 2026-04-06 18:06 by ·º·º2333
[¿¼ÑÐ] 308Çóµ÷¼Á +3 ÖÕ²»ËÆ´Óǰ 2026-04-05 3/150 2026-04-05 20:07 by à£à£à£0119
[¿¼ÑÐ] 322Çóµ÷¼Á +3 àźߺߺã 2026-04-05 3/150 2026-04-05 19:52 by nepu_uu
[¿¼ÑÐ] ¿¼Ñе÷¼ÁÉúѰÕÒµ¼Ê¦ +3 ¹ËÕ°¿¼Ñа¡ 2026-04-05 3/150 2026-04-05 18:18 by à£à£à£0119
[¿¼ÑÐ] 298Çóµ÷¼Á +7 manman511 2026-04-05 7/350 2026-04-05 10:29 by ÌÆãå¶ù
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û